Skip to main content
SpringerLink
Log in

Acute tumor lysis syndrome after rituximab administration in Burkitt’s lymphoma

  • CE - Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Maloney DG, Smith B, Rose A (2002) Rituximab: mechanism of action and resistance. Semin Oncol 29 (1 Suppl 2):2–9

    Article  PubMed  CAS  Google Scholar 

  2. Bienvenu J, Chvetzoff R, Salles G, et al (2001) Groupe d’Etude des Lymphomes de l’Adulte. Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J 2:378–384

    Article  PubMed  CAS  Google Scholar 

  3. Scott SD (1998) Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin’s lymphoma. Cancer Pract 6:195–197

    Article  PubMed  CAS  Google Scholar 

  4. Yang H, Rosove MH, Figlin RA (1999) Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. Am J Hematol 62:247–250

    Article  PubMed  CAS  Google Scholar 

  5. Jensen M, Winkler U, Manzke O, Diehl V, Engert A (1998) Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Ann Hematol 77:89–91

    Article  PubMed  CAS  Google Scholar 

  6. Abou Mourad Y, Taher A, Shamseddine A (2003) Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20. Hematol J 4:222–224

    Article  PubMed  Google Scholar 

  7. Jabr FI (2005) Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma. Int J Hematol 82:312–314

    Article  PubMed  Google Scholar 

  8. Chasty RC, Liu-Yin JA (1993) Acute tumour lysis syndrome. Br J Hosp Med 49:488–492

    PubMed  CAS  Google Scholar 

  9. Lerza R, Botta M, Barsotti B, et al (2002) Dexamethazone-induced acute tumor lysis syndrome in a T-cell malignant lymphoma. Leuk Lymphoma 43:1129–1132

    Article  PubMed  CAS  Google Scholar 

  10. Coutinho AK, de O Santos M, Pinczowski H, Feher O, del Giglio A (1997) Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids. Am J Hematol 54:85–86

    Article  PubMed  CAS  Google Scholar 

  11. Malik IA, Abubakar S, Alam F, Khan A (1994) Dexamethasone-induced tumor lysis syndrome in high-grade non-Hodgkin’s lymphoma. South Med J 87:409–411

    PubMed  CAS  Google Scholar 

  12. Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116:546–554

    Article  PubMed  CAS  Google Scholar 

  13. Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3–11

    Article  PubMed  Google Scholar 

  14. Jasek AM, Day HJ (1994) Acute spontaneous tumor lysis syndrome. Am J Hematol 47:129–131

    Article  PubMed  CAS  Google Scholar 

  15. Lin TS, Lucas MS, Byrd JC (2003) Rituximab in B-cell chronic lymphocytic leukemia. Semin Oncol 30:483–492

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Beirut, Lebanon

    Zaher K. Otrock, Hassan A. Hatoum & Ziad M. Salem

Authors
  1. Zaher K. Otrock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hassan A. Hatoum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ziad M. Salem
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ziad M. Salem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Otrock, Z.K., Hatoum, H.A. & Salem, Z.M. Acute tumor lysis syndrome after rituximab administration in Burkitt’s lymphoma. Intern Emerg Med 3, 161–163 (2008). https://doi.org/10.1007/s11739-008-0099-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-008-0099-1

Keywords

Search

Navigation